J & J Offers to Pay $6.475B to Settle Ovarian Cancer Lawsuits

Johnson and Johnson’s subsidiary LLT Management LLC has agreed to pay $6.475 billion to settle current and future claims that its talc-based products caused ovarian cancer. This is an attempt to try and resolve nearly 54,000 talc cases still awaiting trial against the company.  J&J says the proposition would settle 99.75% of the remaining talc lawsuits it faces in the U.S. However, the proposal won’t settle any remaining mesothelioma lawsuits. The company says it plans to address them separately and has already resolved 95% of its mesothelioma cases.  Claimants now have 3 months to vote on the plan. If accepted, the settlement money will be paid over the course of 25 years. The cases include personal injury and wrongful death lawsuits. Plaintiffs claim talc in the company’s products was contaminated with asbestos, causing ovarian cancer. J&J maintains its products are safe, but stopped selling talc-based products in the U.S. in 2020 and globally in 2022. Cornstarch replaced talc in its products. “The Plan is the culmination of our consensual resolution strategy that we announced last October,” Erik Haas, worldwide vice president of litigation for J&J, said in a statement. “Since then, the Company has worked with counsel representing the overwhelming majority of talc claimants to bring this litigation to a close, which we expect to do through this plan.” J&J’s Connection to Asbestos Court documents sho...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Asbestos (general) Asbestos Exposure Cancer (Non-Meso) Companies johnson Lawsuit Legal Mesothelioma talc Talcum Powder Source Type: news